Live Breaking News & Updates on Shankar Musunuri

Stay updated with breaking news from Shankar musunuri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ocugen, Inc. (NASDAQ:OCGN) Q2 2023 Earnings Call Transcript

Ocugen, Inc. (NASDAQ:OCGN) Q2 2023 Earnings Call Transcript August 22, 2023 Operator: Good morning and welcome to Ocugen’s second quarter 2023 financial results and business update. Please note that this call is being recorded at this time. All participants’ lines are in listen-only mode. Following the speakers’ commentary, there will be a question and answer […] ....

Shankar Musunuri , Jennifer Kim , William Ramakanth , Swayampakula Ramakanth , Tarun Upadhyay , Robert Leboyer , Daniil Gataulin , Pressmaster Shutterstock , Cantor Fitzgerald , A Nuclear , Exchange Commission , Association For Research , Private Securities Litigation Reform Act , Risk Factors , Yes Jennifer , Noble Capital , Tiffany Hamilton , Tarun Upadhyay , Gene Therapy ,

Ocugen Provides Business Update with Second Quarter 2023 Financial Results

Ocugen Provides Business Update with Second Quarter 2023 Financial Results
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Shankar Musunuri , Head Of Communications , Ocugen Inc , Exchange Commission , Association For Research , Conference Call , Webcast Tomorrow , Investigational New Drug , Applications Cleared , Novel Gene Therapies , Geographic Atrophy Secondary , Study Results Update Expected This , Chief Executive Officer , Geographic Atrophy , Mucosal Vaccine Platform , Private Securities Litigation Reform Act ,

Ocugen (OCGN) Q2 2023 Earnings Call Transcript

OCGN earnings call for the period ending June 30, 2023. ....

Jen Kim Cantor Fitzgerald , Jennifer Kim , Daniil Gataulin Chardan , William Ramakanth , Tarun Upadhyay , Shankar Musunuri , Daniil Gataulin , A Nuclear , Shankar Musunuri Co , Association For Research , Tiffany Hamilton Head Of Corporate Communications , Exchange Commission , Cantor Fitzgerald , Tiffany Hamilton , Private Securities Litigation Reform Act , Motley Fool Stock Advisor , Stock Advisor , Risk Factors , Chief Executive , Regenerative Medicine Advanced Therapy , Noble Capital , Capital Markets , Chief Scientific ,

Ocugen Provides Business Update with Second Quarter 2023 Financial Results

Conference Call and Webcast Tomorrow at 8:30 a.m. ET • Investigational New Drug Applications Cleared for Novel Gene Therapies for Geographic Atrophy Secondary to AMD and for Stargardt Disease . ....

Shankar Musunuri , Exchange Commission , Head Of Communications , Ocugen Inc , Association For Research , Conference Call , Webcast Tomorrow , Investigational New Drug , Applications Cleared , Novel Gene Therapies , Geographic Atrophy Secondary , Study Results Update Expected This , Chief Executive Officer , Geographic Atrophy , Mucosal Vaccine Platform , Private Securities Litigation Reform Act ,

Ocugen Provides Business Update with Second Quarter 2023

Conference Call and Webcast Tomorrow at 8:30 a.m. ET • Investigational New Drug (IND) Applications Cleared for Novel Gene Therapies for Geographic Atrophy. ....

Shankar Musunuri , Exchange Commission , Head Of Communications , Association For Research , Ocugen Inc , Conference Call , Webcast Tomorrow , Investigational New Drug , Applications Cleared , Novel Gene Therapies , Geographic Atrophy Secondary , Study Results Update Expected This , Chief Executive Officer , Geographic Atrophy , Mucosal Vaccine Platform , Private Securities Litigation Reform Act , Nasdaq Ocgn ,